Drug Watch | 4 news items

Diabetologia February issue now available

14 January 2015 - Hot Topics, Medical Journals, Drug Watch

The February content of Diabetologia, the official journal of EASD is now available. Below you will find a link to the full content, and an abstract of open access articles selected by the editor, Juleen Zierath. Read more

No magic bullets: more setbacks on the road to immune intervention in type 1 diabetes

6 June 2013 - Hot Topics, Medical Journals, Drug Watch

Read more

Too much of a good thing: further evidence for the harm of dual RAAS blockade

6 November 2012 - Medical Journals, Drug Watch

Inhibition of the renin-angiotensin aldosteron system through the use of Angiotensin Converting Enzyme (ACE) Inhibitors has been a major advance in the prevention of cardiovascular and renal complications in diabetes. The ACE-inhibitors were followed by Angiotensin Receptor Blockers (ARBs) and (...) Read more

ORIGIN: no demonstrable benefits, yet beneficial.

18 September 2012 - Medical Journals, Drug Watch

These days, many of us seem to feel that every new large trial brings new disappointment. Following VADT, ADVANCE and ACCORD, many may have anticipated the negative results of ORIGIN (N Engl J Med 2012; 367:319-328) and the question arises whether any of the currently running large ‘hard-endpoi(...) Read more